NetworkNewsBreaks – Roth Capital Partners Expands Equity Research Team with Adam Walsh and Nick Pope
Roth Capital Partners announced the addition of Adam Walsh, MD and Nicholas (Nick) Pope as Managing Directors and Senior Analysts on its Equity Research team. Walsh will focus on biotechnology, bringing more than 20 years of experience covering rare disease, immunology, genetic medicine and metabolic disease, along with prior CFO roles at jCyte and Catalytic Life Sciences. Pope will cover the oil and gas sector, leveraging both sell-side and buy-side experience, as well as his early career as an ExxonMobil engineer. He previously held positions at Seaport Research Partners, Brookfield Investment, Cowen and JP Morgan. ROTH said the hires strengthen…







